These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33615705)

  • 41. Tumour mismatch repair protein loss is associated with advanced stage in oral cavity squamous cell carcinoma.
    Vasan K; Satgunaseelan L; Anand S; Asher R; Selinger C; Low TH; Palme CE; Clark JR; Gupta R
    Pathology; 2019 Dec; 51(7):688-695. PubMed ID: 31630878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
    Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA mismatch repair abnormalities in acinar cell carcinoma of the pancreas: frequency and clinical significance.
    Liu W; Shia J; Gönen M; Lowery MA; O'Reilly EM; Klimstra DS
    Pancreas; 2014 Nov; 43(8):1264-70. PubMed ID: 25058881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mismatch Repair Deficiency in Endometrial Cancer: Immunohistochemistry Staining and Clinical Implications.
    Doghri R; Houcine Y; Boujelbène N; Driss M; Charfi L; Abbes I; Mrad K; Sellami R
    Appl Immunohistochem Mol Morphol; 2019 Oct; 27(9):678-682. PubMed ID: 31567138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspiration.
    Hosoda W; Takagi T; Mizuno N; Shimizu Y; Sano T; Yamao K; Yatabe Y
    Pathol Int; 2010 May; 60(5):358-64. PubMed ID: 20518885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas.
    McCord M; Steffens A; Javier R; Kam KL; McCortney K; Horbinski C
    Acta Neuropathol Commun; 2020 Feb; 8(1):15. PubMed ID: 32051040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
    Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
    Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical expression of mismatch repair proteins (MSH2, MSH6, MLH1, and PMS2) in prostate cancer: correlation with grade groups (WHO 2016) and ERG and PTEN status.
    Albero-González R; Hernández-Llodrà S; Juanpere N; Lorenzo M; Lloret A; Segalés L; Duran X; Fumadó L; Cecchini L; Lloreta-Trull J
    Virchows Arch; 2019 Aug; 475(2):223-231. PubMed ID: 31209634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix.
    Morgan S; Slodkowska E; Parra-Herran C; Mirkovic J
    Histopathology; 2019 Jun; 74(7):997-1004. PubMed ID: 30667073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
    Zhang YH; Wu HW; Wang J; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653
    [No Abstract]   [Full Text] [Related]  

  • 51. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities.
    Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA
    Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
    Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
    Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.
    Joehlin-Price AS; Perrino CM; Stephens J; Backes FJ; Goodfellow PJ; Cohn DE; Suarez AA
    Gynecol Oncol; 2014 Apr; 133(1):43-7. PubMed ID: 24444820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic neuroendocrine tumors: accurate grading with Ki-67 index on fine-needle aspiration specimens using the WHO 2010/ENETS criteria.
    Farrell JM; Pang JC; Kim GE; Tabatabai ZL
    Cancer Cytopathol; 2014 Oct; 122(10):770-8. PubMed ID: 25044931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic efficacy of cell block immunohistochemistry, smear cytology, and liquid-based cytology in endoscopic ultrasound-guided fine-needle aspiration of pancreatic lesions: a single-institution experience.
    Qin SY; Zhou Y; Li P; Jiang HX
    PLoS One; 2014; 9(9):e108762. PubMed ID: 25259861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma.
    Watkins JC; Nucci MR; Ritterhouse LL; Howitt BE; Sholl LM
    Am J Surg Pathol; 2016 Jul; 40(7):909-16. PubMed ID: 27186853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
    Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
    J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical evaluation of mismatch repair proteins in colorectal carcinoma: the AIFEG/GIPAD proposal.
    Remo A; Fassan M; Lanza G
    Pathologica; 2016 Sep; 108(3):104-109. PubMed ID: 28195261
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mismatch-Repair Protein Expression in High-Grade Gliomas: A Large Retrospective Multicenter Study.
    Caccese M; Ius T; Simonelli M; Fassan M; Cesselli D; Dipasquale A; Cavallin F; Padovan M; Salvalaggio A; Gardiman MP; Skrap M; Zagonel V; Lombardi G
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.